These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 15283926)

  • 1. Skin contamination by oestradiol gel--a remarkable source of error in plasma oestradiol measurements during percutaneous hormone replacement therapy.
    Vihtamäki T; Luukkaala T; Tuimala R
    Maturitas; 2004 Aug; 48(4):347-53. PubMed ID: 15283926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in circulating levels of cardiac natriuretic peptides after hormone replacement therapy in postmenopausal women.
    Maffei S; Del Ry S; Prontera C; Clerico A
    Clin Sci (Lond); 2001 Nov; 101(5):447-53. PubMed ID: 11672449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoactive biomarkers and oxidative stress in healthy recently postmenopausal women treated with hormone replacement therapy.
    Maffei S; Mercuri A; Prontera C; Zucchelli GC; Vassalle C
    Climacteric; 2006 Dec; 9(6):452-8. PubMed ID: 17085378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: results from a randomized placebo-controlled study.
    Sonnet E; Lacut K; Roudaut N; Mottier D; Kerlan V; Oger E
    Clin Endocrinol (Oxf); 2007 May; 66(5):626-31. PubMed ID: 17492948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of topical estradiol on the facial skin collagen of postmenopausal women under oral hormone therapy: a pilot study.
    Patriarca MT; Goldman KZ; Dos Santos JM; Petri V; Simões RS; Soares JM; Simões MJ; Baracat EC
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):202-5. PubMed ID: 16797821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postmenopausal estrogen therapy. Recent aspects of parenteral administration of 17-beta estradiol].
    Andersen HJ; Andreasen E; Jensen HK
    Ugeskr Laeger; 1989 Aug; 151(32):2006-9. PubMed ID: 2672494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral, more than transdermal, oestrogen therapy lowers asymmetric dimethylarginine in healthy postmenopausal women: a randomized, placebo-controlled study.
    Verhoeven MO; Hemelaar M; van der Mooren MJ; Kenemans P; Teerlink T
    J Intern Med; 2006 Feb; 259(2):199-208. PubMed ID: 16420549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen therapy effects on different vasoactive factors in recent postmenopausal healthy women.
    Maffei S; Mercuri A; Zucchelli GC; Vassalle C
    Int J Cardiol; 2006 Feb; 107(2):194-9. PubMed ID: 16412796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of transdermal estrogen replacement therapy on plasma levels of nitric oxide and plasma lipids in postmenopausal women.
    Balci H; Altunyurt S; Acar B; Fadiloglu M; Kirkali G; Onvural B
    Maturitas; 2005 Apr; 50(4):289-93. PubMed ID: 15780528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of intranasal 17beta-estradiol administration on serum bioactive interleukin-6 and C-reactive protein levels in healthy postmenopausal women.
    Rachoń D; Suchecka-Rachoń K; Hak Ł; Myśliwska J
    Menopause; 2006; 13(5):840-5. PubMed ID: 16894332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen replacement therapy decreases plasma adiponectin but not resistin in postmenopausal women.
    Kunnari A; Santaniemi M; Jokela M; Karjalainen AH; Heikkinen J; Ukkola O; Kesäniemi YA
    Metabolism; 2008 Nov; 57(11):1509-15. PubMed ID: 18940387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal estradiol. A potentially improved method of hormone replacement.
    Judd HL
    J Reprod Med; 1994 May; 39(5):343-52. PubMed ID: 8064701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.
    Castelo-Branco C; Palacios S; Vázquez F; Villero J; Ferrer J; Ascaso C; Balasch J
    Fertil Steril; 2007 Aug; 88(2):383-9. PubMed ID: 17561009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of sequential transdermal versus continuous orally administered hormone replacement therapies on plasma total homocysteine levels in postmenopausal women: a randomized, placebo-controlled study.
    Kurtay G; Ozmen B
    Eur J Obstet Gynecol Reprod Biol; 2007 Feb; 130(2):206-11. PubMed ID: 16814449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral but not transdermal estrogen replacement therapy reduced level of tissue factor pathway inhibitor: cross-over designed study.
    Fait T; Vrablik M; Cibula D; Masata J; Hill M; Trnkova B
    Neuro Endocrinol Lett; 2006 Oct; 27(5):665-8. PubMed ID: 17159824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D; Conradt C; Jesinger D; Bakowski M
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different effects of transdermal and oral hormone replacement therapy on the renin-angiotensin system, plasma bradykinin level, and blood pressure of normotensive postmenopausal women.
    Ichikawa J; Sumino H; Ichikawa S; Ozaki M
    Am J Hypertens; 2006 Jul; 19(7):744-9. PubMed ID: 16814131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of dydrogesterone and norethisterone, in combination with oestradiol, on lipoproteins and inflammatory markers in postmenopausal women.
    Kwok S; Charlton-Menys V; Pemberton P; McElduff P; Durrington PN
    Maturitas; 2006 Mar; 53(4):439-46. PubMed ID: 16139447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum estrogen level after hormone replacement therapy and body mass index in postmenopausal and bilaterally ovariectomized women.
    Yasui T; Uemura H; Umino Y; Takikawa M; Saito S; Kuwahara A; Matsuzaki T; Maegawa M; Furumoto H; Miura M; Irahara M
    Maturitas; 2005 Jan; 50(1):19-29. PubMed ID: 15590210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.